Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Capital Leases (2016 - 2018)

Surgery Partners (SGRY) has disclosed Capital Leases for 5 consecutive years, with $25.4 million as the latest value for Q4 2018.

  • Quarterly Capital Leases changed N/A to $25.4 million in Q4 2018 from the year-ago period, while the trailing twelve-month figure was $25.4 million through Dec 2018, changed N/A year-over-year, with the annual reading at $25.4 million for FY2018, N/A changed from the prior year.
  • Capital Leases hit $25.4 million in Q4 2018 for Surgery Partners, up from $24.8 million in the prior quarter.
  • In the past five years, Capital Leases ranged from a high of $52.7 million in Q4 2016 to a low of $10.3 million in Q3 2015.
  • Historically, Capital Leases has averaged $19.6 million across 5 years, with a median of $14.8 million in 2017.
  • Biggest five-year swings in Capital Leases: grew 5.22% in 2015 and later soared 365.71% in 2016.
  • Year by year, Capital Leases stood at $10.8 million in 2014, then increased by 5.22% to $11.3 million in 2015, then skyrocketed by 365.71% to $52.7 million in 2016, then tumbled by 71.94% to $14.8 million in 2017, then skyrocketed by 71.6% to $25.4 million in 2018.
  • Business Quant data shows Capital Leases for SGRY at $25.4 million in Q4 2018, $24.8 million in Q3 2018, and $25.4 million in Q2 2018.